Agenda Topics- Apoptosis Assays
- Assays for Phenotypic Changes: Invasion, Migration, Angiogenesis
- Case Studies from Biotechnology and Pharmaceutical Companies
- Elements of Assay Development: A Nuts-and-Bolts Perspective
- High-Content Analysis (HCA) Assays
- Instrumentation for Cell-based Assays
- Metabolism-monitoring Assays
- Morphology Changes as a Readout
- Reporter Gene Assays and their Utility for Drug Discovery Projects
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to datePeter Antinozzi, Assistant Professor, Wake Forest University School of Medicine Anne Bang, Director, Sanford Burnham Medical Research Institute Nathan Bays, Senior Therapeutic Scientist, Merck and Co Inc Robert Damoiseaux, Scientific Director, University of California Los Angeles Anthony Mitchell Davies, Director, Trinity College Dublin Cedric Gaggioli, Baby Team Leader, Université Nice Sophia Antipolis Sung Wook Jang, Investigator, National Institutes of Health (NIH) Eric Johnson, Associate Professor, University of Wisconsin Jeffrey Kelly, Researcher, Promega Robin Ketteler, Group Leader/Manager, University College London Aydogan Ozcan, Chancellor's Professor, University of California-Los Angeles; Associate Director, California NanoSystems Institute (CNSI) Michel Roberge, Scientific Director, University of British Columbia Roland Wolkowicz, Associate Professor, San Diego State University
|